P2X Receptor

P2X receptor antagonists and modulators act on ion channels gated by extracellular adenosine triphosphate (ATP). Cloning of the P2X1 and P2X2 subunits in 1994 defined a new structural class of ligand-gated ion channels. Seven subunits, P2X1 to P2X7, assemble as trimers that pass sodium, potassium and calcium ions. P2X3 and P2X2/3 receptors on sensory neurons are studied in pain signaling, and P2X7 receptors in inflammation. In 1996 the cytolytic P2Z receptor of macrophages was identified as P2X7, which opens large pores during sustained ATP exposure. A-317491 sodium salt hydrate and AF-353 block P2X3 and P2X2/3 receptors. A 740003 and A 438079 hydrochloride are P2X7 antagonists, whereas NF 279 acts at P2X1.

Items 76-94 of 94

  • P2X7 receptor antagonist-5
    Cat. No.
    A67928

    P2X7 receptor antagonist-5

    P2X7 receptor antagonist-5 is a potent inhibitor of the P2X7 receptor, a crucial target in various inflammatory and neurological disorders. This compound is characterized by its oral bioavailability and prolonged action, making it suitable for in vivo studies. It holds potential for applications in researching pain, neurodegeneration, and immune responses linked to P2X7 receptor signaling.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • P2X7 receptor antagonist-3
    Cat. No.
    A67929

    P2X7 receptor antagonist-3

    P2X7 receptor antagonist-3 is a highly potent antagonist of the P2X7 receptor, demonstrating IC50 values of 4.2 nM in human cells and 6.8 nM in rat models. This compound inhibits the activation of the P2X7 receptor, which is involved in inflammatory responses and various signaling pathways. It is suitable for research applications focused on pain, neuroinflammation, and autoimmune diseases, enabling the exploration of therapeutic strategies targeting P2X7 receptor-mediated mechanisms.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • GSK1370319A
    Cat. No.
    A67930

    GSK1370319A

    GSK1370319A is a selective inhibitor of the human P2X7 receptor, demonstrating an IC50 of 474 nM and a Ki of 176 nM. This compound effectively inhibits the production of interleukin-1 beta (IL-1β), decreases the generation of reactive oxygen species (ROS), and enhances macrophage survival rates. GSK1370319A is applicable in research related to inflammatory bowel disease and the broader study of inflammatory processes.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • P2X receptor-1
    Cat. No.
    A67931

    P2X receptor-1

    P2X receptor-1 is a selective inhibitor of P2X receptors, which play a critical role in mediating pain and inflammatory responses. This compound has potential applications in research focused on understanding nociception and addressing inflammatory conditions. Its ability to modulate P2X receptor activity makes it an important tool for exploring therapeutic strategies in pain management and inflammation research.

    Out of stock

    All 3 sizes
  • MRS 2219
    Cat. No.
    A67932

    MRS 2219

    Synonyms: Pyridoxol; cyclic 3,4-hydrogen phosphate

    MRS 2219 is a selective pharmacological probe for the P2X1 receptor, primarily functioning as an antagonist. It enhances ATP-evoked responses at P2X1 receptors with an EC50 of 5.9 μM, making it essential for studies involving purinergic signaling in cardiovascular and neurological research. This compound is particularly valuable for elucidating the role of P2X1 receptors in various physiological processes and pathological conditions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • α,β-Methylene-ATP
    Cat. No.
    A67933

    α,β-Methylene-ATP

    α,β-Methylene-ATP is a selective agonist of the P2X1 and P2X3 receptors, capable of crossing the blood-brain barrier. Its activation of P2X receptors induces a reflex pressor response associated with the peripheral muscles and the central locus coeruleus, while engaging noradrenergic neurons that mediate antinociceptive effects. α,β-Methylene-ATP is a valuable tool for investigating neuropathic pain mechanisms, cardiovascular reflex regulation, and the central nervous system's antinociceptive pathways.

    25 mg
    $1,780.00
    50 mg
    $2,280.00
    All 3 sizes
  • P2X2/3 modulator-1
    Cat. No.
    A67934

    P2X2/3 modulator-1

    P2X2/3 modulator-1 is a selective modulator targeting the P2X2 and P2X3 purinergic receptors. This compound exhibits significant biological activity in the modulation of pain pathways and inflammation processes. It is applicable in research focused on pain management, central nervous system disorders, and inflammatory conditions, providing insights into therapeutic strategies for these ailments.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • NP-1815-PX
    Cat. No.
    A67935

    NP-1815-PX

    NP-1815-PX is a selective antagonist of the P2X4 receptor, demonstrating potent inhibition of this target. It exhibits significant anti-inflammatory properties and has been shown to alleviate pain in chronic pain models. Additionally, NP-1815-PX effectively inhibits contractions in guinea pig tracheal and bronchial smooth muscle, making it a valuable tool for research in respiratory and pain-related studies.

    Out of stock

    All 3 sizes
  • HW091077
    Cat. No.
    A67936

    HW091077

    HW091077 is a selective antagonist of the P2X3 receptor, exhibiting an IC50 of 17 nM. By inhibiting ATP-induced calcium influx and preventing cell depolarization, HW091077 effectively disrupts cough reflex pathways. This compound holds potential for research applications focused on chronic cough mechanisms.

    Out of stock

    All 3 sizes
  • P2X7 receptor antagonist-6
    Cat. No.
    A67937

    P2X7 receptor antagonist-6

    P2X7 receptor antagonist-6 is a negative allosteric modulator targeting the P2X7 receptor, exhibiting an IC50 of 1.31 μM for human P2X7. This compound demonstrates potential for research applications in cancer, neurodegenerative disorders, inflammatory responses, and infectious diseases, contributing to a greater understanding of P2X7's role in these conditions. Its specificity and efficacy make it a valuable tool for exploring therapeutic pathways in related research fields.

    Out of stock

    All 3 sizes
  • α,β-Methylene-ATP dilithium
    Cat. No.
    A67938

    α,β-Methylene-ATP dilithium

    α,β-Methylene-ATP dilithium is a selective agonist for P2X1 and P2X3 receptors, capable of crossing the blood-brain barrier. It induces a reflex pressor response by activating these receptors in peripheral muscles and the central locus coeruleus, with effects that can be inhibited by the P2X antagonist PPADS. Additionally, it stimulates noradrenergic neurons in the central locus coeruleus, contributing to antinociceptive effects that can be reduced by DSP-4. This compound is valuable for investigating the mechanisms underlying neuropathic pain, cardiovascular reflex regulation, and central nervous system analgesia.

    25 mg
    $3,260.00
    All 1 sizes
  • AZD9056
    Cat. No.
    A67939

    AZD9056

    AZD9056 is a potent antagonist of the P2X7 purinergic receptor, which plays a significant role in cancer progression. This compound exhibits notable anticancer activity by inhibiting the invasion and metastasis of cancer stem cells. As a result, AZD9056 is valuable for research focused on cancer biology and novel therapeutic strategies targeting purinergic signaling pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Ap4G
    Cat. No.
    A67940

    Ap4G

    Ap4G is a dinucleoside polyphosphate that functions as a vasoconstrictor by modulating P2 receptors, particularly P2X receptors. This compound is instrumental for research into vascular physiology and pathology, providing insights into mechanisms of vasoconstriction and related cardiovascular conditions. Its distinct biological activity makes it a valuable reagent for studies investigating the role of purinergic signaling in vascular health.

    Out of stock

    All 3 sizes
  • ITH15004
    Cat. No.
    A67942

    ITH15004

    ITH15004 is a potent antagonist of the P2X7 receptor, effectively penetrating the central nervous system. This compound is utilized in research focused on neurodegenerative diseases, providing insights into the role of ATP-gated ion channels in neuroinflammation and neuronal cell death. Its ability to modulate P2X7 receptor activity makes it a valuable tool in understanding therapeutic strategies for neurological disorders.

    1 mg
    $105.00
    5 mg
    $320.00
    All 4 sizes
  • NF449
    Cat. No.
    A67944

    NF449

    NF449 is a potent antagonist of the P2X1 receptor, demonstrating IC50 values of 0.28 nM for rP2X1, 0.69 nM for rP2X1+5, and 120 nM for P2X2+3. It selectively inhibits Gsα coupling, suppressing GTP[γS] binding to Gsα-s and diminishing adenylyl cyclase activity. This compound is crucial for research applications involving the modulation of purinergic signaling and studies related to cardiovascular and inflammatory conditions.

    Out of stock

    All 3 sizes
  • P2X4 antagonist-5
    Cat. No.
    A67945

    P2X4 antagonist-5

    P2X4 antagonist-5 is a selective antagonist for the P2X4 receptor, exhibiting an IC50 greater than 100 μM in human P2X4 assays. This compound serves as a control in studies investigating the modulation of P2X4 receptor activity. It is useful for researchers examining the role of purinergic signaling in various physiological and pathological processes.

    500 mg
    $25.00
    1 g
    $40.00
    All 5 sizes
  • TC-P 262
    Cat. No.
    A67946

    TC-P 262

    TC-P 262 is a highly effective inhibitor of the P2X3 receptor, a key player in pain and inflammatory responses. By binding to the human P2X3 receptor, TC-P 262 demonstrates significant inhibitory effects, making it a valuable tool for studying conditions such as rheumatoid arthritis, chronic cough, and pain management. This reagent facilitates the exploration of P2X3's role in these biological processes, contributing to the understanding of potential therapeutic interventions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Diadenosine pentaphosphate (pentasodium)
    Cat. No.
    A71289

    Diadenosine pentaphosphate (pentasodium)

    Diadenosine pentaphosphate (pentasodium) is an agonist and negative modulator of the P2X1 receptor, an important endogenous purine dinucleotide primarily sourced from platelets. This compound is known to negatively regulate dendritic growth and branching by activating both homologous and heterologous P2X1 receptors, resulting in a modest transient increase in intracellular calcium levels in dendritic growth cones. Diadenosine pentaphosphate demonstrates selective inhibition of dendrite growth in cultured hippocampal neurons while leaving axon growth unaffected. Its presence in secretory vesicles such as platelets and brain synaptosomes highlights its biological relevance in neurophysiological studies.

    1 mg
    $115.00
    5 mg
    $355.00
    All 3 sizes
  • GSK-1482160 (isomer)
    Cat. No.
    B10906

    GSK-1482160 (isomer)

    GSK-1482160 isomer functions as a negative allosteric modulator of the P2X7 receptor (P2X7R), exhibiting oral bioavailability and the ability to penetrate the blood-brain barrier. With pIC50 values of 8.5 for human and 6.5 for rat, this compound effectively diminishes ATP's efficacy at P2X7R without altering its affinity, thus inhibiting the release of IL-1β. Additionally, GSK-1482160 serves as an excellent radioligand, available for labeling with isotopes such as 11C or 18F for imaging studies. Its applications extend to the investigation of chronic joint pain and the chronic constriction injury (CCI) model.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes

Items 76-94 of 94

Added to your cart

View Cart Checkout

    Loading...